|
|
||||||||
Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom
Correspondence: For reprints contact: K. E. Britton, MD, Dept. of Nuclear Medicine, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE UK.
ABSTRACT
A Phase I study in 12 patients with renal disorders compared the simultaneous clearances of 99mTc-labeled mercaptoacetyltriglycine (MAG3) and 131I-labeled orthoiodohippurate (OIH). The ratio of MAG3 to OIH clearance was 0.61 ± 0.08 as a result of its smaller volume of distribution, ratio 0.65 ± 0.09, for the clearance half-lives were similar, ratio 1.09 ± 0.12.A Phase II study performed serially in 20 patients with equal doses of [99mTc]MAG3 and [123I]OIH gave images of equal quality. The relative renal functions were highly correlated (r = 0.97, p < 0.001) and transit time analyses gave good correlations: parenchymal transit time index r = 0.81, p < 0.05. We conclude that [99mTc]MAG3 has some advantages over [99mTc]DTPA and is a suitable replacement for [123I]hippuran in routine renal imaging, relative function, and transit time studies, but not for the accurate estimation of the renal plasma flow.
This article has been cited by other articles:
![]() |
M. P. Diaz, E. E. Aparicio, O. D. Rizo, R. R. Diaz, and C. H. Rodriguez Administered Activity Optimization in 99mTc-MAG3 Renography for Adults J. Nucl. Med. Technol., December 1, 2003; 31(4): 216 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sitek, G. T. Gullberg, E. V.R. Di Bella, and A. Celler Reconstruction of Dynamic Renal Tomographic Data Acquired by Slow Rotation J. Nucl. Med., November 1, 2001; 42(11): 1704 - 1712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |